Helping Healthcare Providers Avoid Liability Through Pharmacogenomics
Precision Medicine Hero/ Pharmacist Entrepreneurs Network
Sparking innovative ways for white coats to think, earn and thrive in today's world.
Pharmacists play a pivotal role in mitigating healthcare provider (HCP) liability risks through pharmacogenomic (PGx) testing. By collaborating with pharmacists, HCPs can offload the complexities of test interpretation and medication management, ensuring safer, more effective care for their patients.
The Risks of Ignoring PGx Testing
Failure to incorporate PGx testing may lead to preventable adverse drug reactions (ADRs), hospitalizations, or suboptimal patient outcomes. ADRs account for 10% of hospital admissions and 20% of readmissions, contributing $30 billion annually in U.S. healthcare costs.
Providers who fail to adjust prescriptions based on known genetic factors may face malpractice claims, as the standard of care shifts toward precision medicine. For example, CYP2C19 genotyping for patients prescribed clopidogrel has been shown to reduce cardiac events by up to 30%, demonstrating the clear clinical and legal implications.
Pharmacists: Partners in Reducing Liability
Pharmacists, as PGx experts, reduce the risk of ADRs and ensure compliance with evidence-based guidelines. Their contributions:
In multidisciplinary settings, 90% of prescribers reported greater confidence when pharmacists were involved in PGx-guided prescribing.
Opportunities to Learn More
For HCPs interested in integrating PGx testing into their practice, we invite you to join our upcoming Precision Medicine Hero (PMH) webinar or book a 1:1 call with Melissa Smith, PharmD, CPH.
During these sessions, we’ll discuss how PGx enhances safety and improves outcomes across treatment areas, including its critical role in breast cancer care, where genetic insights are saving lives and driving progress in personalized medicine.
Warm regards,
Director of Community Engagement and Professional Mentorship Precision Medicine Hero